Literature DB >> 29527638

Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Muhammad M Fareed1, Rizwan Ishtiaq2, Thomas J Galloway3.   

Abstract

OPINION STATEMENT: Overall radiation treatment time has long been recognized as an important factor in head and neck tumor control. The concern of tumor growth in waiting time either before starting radiotherapy or during treatment is substantial given its negative impact on clinical outcome. There is an overwhelming evidence that increasing the time to initiate treatment increases the tumor burden and worsens the prognosis. This effect is more pronounced especially in patients with an early stage cancer disease. Delay in treatment initiation is contributed by both health care- and patient-related factors. Health care-related factors include advancement in diagnostic modalities and transfer of patient to academic health care centers accompanied by delayed referrals and long-awaited appointments. Patient-related factors include delayed reporting time and socioeconomic factors. An efficient transition of care along with access of cancer care modalities to community health care centers will not only improve the quality of care in secondary health care centers but also help decrease the patient burden in tertiary centers. A quick and well-structured multidisciplinary appointment program is fundamental in shortening the time required for patient referrals, thus increasing the optimal survival time for Head and Neck cancer patients with early initiation of treatment.

Entities:  

Keywords:  Head and neck cancers; Radiation therapy; Radiation treatment time; Time to treatment initiation; Treatment package time

Mesh:

Year:  2018        PMID: 29527638     DOI: 10.1007/s11864-018-0534-0

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  62 in total

1.  FDG PET reimbursement.

Authors:  Jim Bietendorf
Journal:  J Nucl Med Technol       Date:  2004-03

2.  Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE.

Authors:  Luigi Siciliani; Rossella Verzulli
Journal:  Health Econ       Date:  2009-11       Impact factor: 3.046

3.  Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial.

Authors:  A Trotti; D Klotch; J Endicott; M Ridley; A Cantor
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

Review 4.  Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.

Authors:  J Overgaard; J Alsner; J Eriksen; M R Horsman; C Grau
Journal:  Rays       Date:  2000 Jul-Sep

5.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Authors:  Talha Shaikh; Elizabeth A Handorf; Colin T Murphy; Ranee Mehra; John A Ridge; Thomas J Galloway
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-06       Impact factor: 7.038

6.  Influence of time delay and clinical upstaging in the prognosis of head and neck cancer.

Authors:  L P Kowalski; A L Carvalho
Journal:  Oral Oncol       Date:  2001-01       Impact factor: 5.337

7.  Socioeconomic status and comorbidity among newly diagnosed cancer patients.

Authors:  C T Schrijvers; J W Coebergh; J P Mackenbach
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

8.  Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Lora Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  Cancer       Date:  2014-12-09       Impact factor: 6.860

9.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

Authors:  S Webb; A E Nahum
Journal:  Phys Med Biol       Date:  1993-06       Impact factor: 3.609

10.  Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA).

Authors:  Véronique Christophe; Tanguy Leroy; Mélanie Seillier; Camille Duthilleul; Morbize Julieron; Stéphanie Clisant; Jérôme Foncel; Fanny Vallet; Jean-Louis Lefebvre
Journal:  BMJ Open       Date:  2014-07-25       Impact factor: 2.692

View more
  2 in total

1.  Racial and Treatment Center Differences on Time to Treatment Initiation for Nonsmall Cell Lung Cancer Patients Receiving Radiation Therapy As an Initial Treatment.

Authors:  Akhil Rekulapelli; Raj P Desai; Aditya Narayan; Linda W Martin; Richard Hall; James M Larner; Rajesh Balkrishnan
Journal:  Health Equity       Date:  2022-08-18

2.  Association between treatment package time and clinical predictors in oropharyngeal cancer.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Hidenori Tsuzuki; Masami Nishio; Daisuke Nishikawa; Shintaro Beppu; Nobuhiro Hanai
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.